Which Is Better? Ascena Retail Group Inc (ASNA), HMS Holdings Corp (HMSY) and Sunesis Pharmaceuticals, Inc. (SNSS)

Posted by admin May 5, 2015 0 Comment 447 views


New York, NY – GDP INSIDER  –  05/05/2014.

This article discusses three companies: Ascena Retail Group Inc (NASDAQ:ASNA), HMS Holdings Corp (NASDAQ:HMSY) and Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)

Ascena Retail Group Inc (NASDAQ:ASNA) reversed its upward trend yesterday with the stock closing down 1.18%or $0.18 to close the day at $15.05 with more than 0.954 million shares trading hands, compared to its three month average trading volume of 1.41 million. The specialty retailer offering clothing, shoes and accessories for women has been performing well so far this year with the stock up 19.82%, outperforming the S&P 500 which has gained only 2.70% for the same period. With one year price target estimate of $15.50 and diluted EPS of $0.69, the company is a hold with a look to buy.

Can Ascena Retail Group Inc Climb Higher In Near Future? Take A Closer Look With Free ASNA Analysis.

HMS Holdings Corp (NASDAQ:HMSY) saw a minuscule gain of 0.35% as the stock gained six cents to finish the day at a closing price of $17.20 yesterday with only 0.993 shares changing hands compared with its three month average trading volume of 1.16 million. The stock traded towards the bottom end of its 52 week range after opening the day at $17.16. The cost containment services provider to government and private healthcare payers has been declining since the beginning of the year, with the stock down 18.64% YTD and 23.18% over the past six months. With P/E of 107.50 and quarterly revenue growth of -7.70%, it is better to sell than hold for now.

Is HMS Holdings Corp A Good Medium Term Investment? Take A Look At The technical Indicators With Our Free HMSY Analysis.

Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) reversed its recent downward trend yesterday closing up 1.77% or $0.04 to finish the day at a closing price of $2.30 on fairly light trading volume of 0.995 million, compared to its three month average trading volume of 1.02 million. Sunesis Pharmaceuticals, Inc’s decline in value came despite the fact that the company did not make any significant announcement or release any financial figure. The biopharmaceutical company has been trading within a range of $1.00 to $8.45 over the past one year. With one year target price estimate of $3.38 and quarterly earnings growth of 84.60% year on year, the stock has solid investment potential, hold.

Will Sunesis Pharmaceuticals, Inc Increase Its Medium term? Click Here For Our Free SNSS Analysis.

About Ultimate Stock Alerts

UltimateStockAlerts.com covers NASDAQ and NYSE listed companies that are overlooked by Wall Street. Investors can choose to receive trading strategies via text message (SMS) or email. To receive free text message alerts text the word ULTIMATE to 555888 from your cell phone. For more information visit www.UltimateStockAlerts.com

Disclosure:  UltimateStockAlerts.com is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit www.UltimateStockAlerts.com website, for complete risks and disclosures.


Write Your Comment